» Articles » PMID: 37450586

Targeting and Arginine-driven Synergizing Photodynamic Therapy with Nutritional Immunotherapy Nanosystems for Combating MRSA Biofilms

Overview
Journal Sci Adv
Specialties Biology
Science
Date 2023 Jul 14
PMID 37450586
Authors
Affiliations
Soon will be listed here.
Abstract

The resistance and immune escape of methicillin-resistant (MRSA) biofilms cause recalcitrant infections. Here, we design a targeting and synergizing cascade PDT with nutritional immunotherapy nanosystems (Arg-PCN@Gel) containing PCN-224 as PDT platform for providing reactive oxygen species (ROS), incorporating arginine (Arg) as nitric oxide (NO) donor to cascade with ROS to produce more lethal ONOO and promote immune response, and coating with gelatin as targeting agent and persistent Arg provider. The nanosystems adhered to the autolysin of MRSA and inhibited Arg metabolism by down-regulating and . It suppressed polysaccharide intercellular adhesin and extracellular DNA synthesis to prevent biofilm formation. The NO broke mature biofilms and helped ROS and ONOO penetrate into biofilms to inactivate internal MRSA. Arg-PCN@Gel drove Arg to enhance immunity via inducible NO synthase/NO axis and arginase/polyamine axis and achieve efficient target treatment in MRSA biofilm infections. The targeting and cascading PDT synergized with nutritional immunotherapy provide an effective promising strategy for biofilm-associated infections.

Citing Articles

Blue light-activated 5,10,15,20-tetrakis(4-bromophenyl)porphyrin for photodynamic eradication of drug-resistant .

Qin H, Niu H, Guo Y, Wang X, Liu T, Zhao C RSC Adv. 2024; 14(53):39779-39786.

PMID: 39697839 PMC: 11653106. DOI: 10.1039/d4ra07666d.


An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers.

Qi X, Xiang Y, Li Y, Wang J, Chen Y, Lan Y Bioact Mater. 2024; 45:301-321.

PMID: 39669125 PMC: 11635604. DOI: 10.1016/j.bioactmat.2024.11.029.


mRNA-based platform for preventing and treating by targeted staphylococcal enterotoxin B.

Luo F, Xu C, Zhang C, Tan A, Lu D, Luo P Front Immunol. 2024; 15:1490044.

PMID: 39640268 PMC: 11617584. DOI: 10.3389/fimmu.2024.1490044.


Nanocatalytic medicine enabled next-generation therapeutics for bacterial infections.

Ge M, Jiang F, Lin H Mater Today Bio. 2024; 29:101255.

PMID: 39381264 PMC: 11459013. DOI: 10.1016/j.mtbio.2024.101255.


Anti-inflammatory effects of 1,7-dihydroxy-3,4-dimethoxyxanthone through inhibition of M1-phenotype macrophages via arginine/mitochondrial axis.

Liu X, Wang T, Xiang R, Sun H, Zhao M, Ye X Immunol Res. 2024; 72(6):1404-1416.

PMID: 39349673 DOI: 10.1007/s12026-024-09538-w.


References
1.
Liao X, Li H, Guo Y, Yang F, Chen Y, He X . Regulation of DNA-binding activity of the Staphylococcus aureus catabolite control protein A by copper (II)-mediated oxidation. J Biol Chem. 2022; 298(3):101587. PMC: 8847796. DOI: 10.1016/j.jbc.2022.101587. View

2.
von Eiff C, Peters G, Becker K . The small colony variant (SCV) concept -- the role of staphylococcal SCVs in persistent infections. Injury. 2006; 37 Suppl 2:S26-33. DOI: 10.1016/j.injury.2006.04.006. View

3.
Wan M, Chen H, Wang Q, Niu Q, Xu P, Yu Y . Bio-inspired nitric-oxide-driven nanomotor. Nat Commun. 2019; 10(1):966. PMC: 6393443. DOI: 10.1038/s41467-019-08670-8. View

4.
Hou J, Pan Y, Zhu D, Fan Y, Feng G, Wei Y . Targeted delivery of nitric oxide via a 'bump-and-hole'-based enzyme-prodrug pair. Nat Chem Biol. 2019; 15(2):151-160. DOI: 10.1038/s41589-018-0190-5. View

5.
Sprenger M, Fukuda K . ANTIMICROBIAL RESISTANCE. New mechanisms, new worries. Science. 2016; 351(6279):1263-4. DOI: 10.1126/science.aad9450. View